Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 29, 2025 • 9:00 PM ET

Date/Time Source News Release
05/28/2025 07:00 AM EDT GlobeNewswire Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
05/13/2025 04:01 PM EDT GlobeNewswire Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
05/05/2025 08:00 AM EDT GlobeNewswire Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
04/28/2025 04:01 PM EDT GlobeNewswire Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
03/27/2025 04:01 PM EDT GlobeNewswire Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
03/18/2025 08:00 AM EDT GlobeNewswire Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025
02/25/2025 10:15 AM EST GlobeNewswire UPDATE - Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
02/25/2025 07:00 AM EST GlobeNewswire Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
01/10/2025 07:00 AM EST GlobeNewswire Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
11/14/2024 04:05 PM EST GlobeNewswire Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update
Page

Additional News

As of June 29, 2025 • 9:00 PM ET

Date/Time Source News Release
06/11/2025 03:20 PM EDT SeekingAlpha Spero Therapeutics -- Additional Upside Potential Following Positive Phase 3 Results
05/29/2025 11:18 AM EDT Zacks SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal
05/28/2025 05:50 PM EDT AllPennyStocks.com Biotech Finds Mid-Week Success After Meeting Primary Endpoint
05/28/2025 09:54 AM EDT 24/7 Market News Biotech Today: From Sustainable Biomaterials to First-in-Class Therapies
05/28/2025 07:52 AM EDT SeekingAlpha Spero surges as GSK-partnered UTI candidate succeeds in late-stage trial
05/28/2025 07:35 AM EDT 24/7 Market News Spero Therapeutics and GSK Announce Early Completion of Phase 3 PIVOT-PO Trial for Oral Antibiotic Tebipenem HBr Based on Positive Efficacy Results
05/13/2025 05:10 PM EDT Zacks Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates
05/13/2025 04:03 PM EDT SeekingAlpha Spero Therapeutics GAAP EPS of -$0.25 beats by $0.30, revenue of $5.87M
05/13/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.